Journal articles on the topic 'CUA a CBA'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'CUA a CBA.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Dao, Thi D. "The Application of CBA to Pharmaceuticals: Going from CBA to CEA to CUA." Drug Information Journal 22, no. 3 (1988): 317–21. http://dx.doi.org/10.1177/009286158802200305.
Full textSvensson, Mikael, and Lars Hultkrantz. "A Comparison of Cost-Benefit and Cost-Effectiveness Analysis in Practice: Divergent Policy Practices in Sweden." Nordic Journal of Health Economics 5, no. 2 (2017): 41–53. http://dx.doi.org/10.5617/njhe.1592.
Full textWard, C. A., D. McCullough, and W. D. Fraser. "Relation between complement activation and susceptibility to decompression sickness." Journal of Applied Physiology 62, no. 3 (1987): 1160–66. http://dx.doi.org/10.1152/jappl.1987.62.3.1160.
Full textSohal, Davendra, Feng Lin, Suman Kundu, Keith McCrae, and Alok A. Khorana. "Complement levels as predictors of survival in pancreatic adenocarcinoma." Journal of Clinical Oncology 36, no. 4_suppl (2018): 315. http://dx.doi.org/10.1200/jco.2018.36.4_suppl.315.
Full textGreer, J. "Comparative Structural Anatomy of the Complement Anaphylatoxin Proteins C3a, C4a and C5a." Enzyme 36, no. 1-2 (1986): 150–63. http://dx.doi.org/10.1159/000469285.
Full textKwon, So Hyun, Jung Eun Park, Yeong Hee Cho, and Jung Sup Lee. "Effect of Vibrio-Derived Extracellular Protease vEP-45 on the Blood Complement System." Biology 10, no. 8 (2021): 798. http://dx.doi.org/10.3390/biology10080798.
Full textMarc, Mateja M., Peter Korosec, Mitja Kosnik, et al. "Complement Factors C3a, C4a, and C5a in Chronic Obstructive Pulmonary Disease and Asthma." American Journal of Respiratory Cell and Molecular Biology 31, no. 2 (2004): 216–19. http://dx.doi.org/10.1165/rcmb.2003-0394oc.
Full textDaffern, P. J., P. H. Pfeifer, J. A. Ember, and T. E. Hugli. "C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation." Journal of Experimental Medicine 181, no. 6 (1995): 2119–27. http://dx.doi.org/10.1084/jem.181.6.2119.
Full textElsner, J., M. Oppermann, W. Czech, and A. Kapp. "C3a activates the respiratory burst in human polymorphonuclear neutrophilic leukocytes via pertussis toxin-sensitive G-proteins." Blood 83, no. 11 (1994): 3324–31. http://dx.doi.org/10.1182/blood.v83.11.3324.3324.
Full textElsner, J., M. Oppermann, W. Czech, and A. Kapp. "C3a activates the respiratory burst in human polymorphonuclear neutrophilic leukocytes via pertussis toxin-sensitive G-proteins." Blood 83, no. 11 (1994): 3324–31. http://dx.doi.org/10.1182/blood.v83.11.3324.bloodjournal83113324.
Full textKim, Song-Yi, Hyangsook Lee, Younbyoung Chae, Hi-Joon Park, and Hyejung Lee. "A Systematic Review of Cost-Effectiveness Analyses Alongside Randomised Controlled Trials of Acupuncture." Acupuncture in Medicine 30, no. 4 (2012): 273–85. http://dx.doi.org/10.1136/acupmed-2012-010178.
Full textKlos, Andreas, Elisabeth Wende, Kathryn J. Wareham, and Peter N. Monk. "International Union of Basic and Clinical Pharmacology. LXXXVII. Complement Peptide C5a, C4a, and C3a Receptors." Pharmacological Reviews 65, no. 1 (2013): 500–543. http://dx.doi.org/10.1124/pr.111.005223.
Full textMorales, Rommel, Lingjun Zhang, Yuping Wu, et al. "C3a, C4a, and C5a Complement Anaphylatoxins Are Paradoxically Decreased in Acute and Chronic Heart Failure." Journal of Cardiac Failure 26, no. 10 (2020): S19—S20. http://dx.doi.org/10.1016/j.cardfail.2020.09.063.
Full textBautsch, W., T. Kretzschmar, T. Stühmer, et al. "A recombinant hybrid anaphylatoxin with dual C3a/C5a activity." Biochemical Journal 288, no. 1 (1992): 261–66. http://dx.doi.org/10.1042/bj2880261.
Full textAntovic, Aleksandra, Fariborz Mobarrez, Milena Manojlovic, et al. "Microparticles Expressing Myeloperoxidase and Complement C3a and C5a as Markers of Renal Involvement in Antineutrophil Cytoplasmic Antibody–associated Vasculitis." Journal of Rheumatology 47, no. 5 (2019): 714–21. http://dx.doi.org/10.3899/jrheum.181347.
Full textBanadakoppa, Manu, Alex C. Vidaeff, Uma Yallampalli, Susan M. Ramin, Michael A. Belfort, and Chandra Yallampalli. "Complement Split Products in Amniotic Fluid in Pregnancies Subsequently Developing Early-Onset Preeclampsia." Disease Markers 2015 (2015): 1–7. http://dx.doi.org/10.1155/2015/263109.
Full textEmeis, Michael, Josef Sonntag, Carsten Willam, Evelyn Strauss, Matthias M. Walka, and Michael Obladen. "Acidosis activates complement systemin vitro." Mediators of Inflammation 7, no. 6 (1998): 417–20. http://dx.doi.org/10.1080/09629359890802.
Full textSchatz-Jakobsen, Janus Asbjørn, Laure Yatime, Casper Larsen, Steen Vang Petersen, Andreas Klos, and Gregers Rom Andersen. "Structural and functional characterization of human and murine C5a anaphylatoxins." Acta Crystallographica Section D Biological Crystallography 70, no. 6 (2014): 1704–17. http://dx.doi.org/10.1107/s139900471400844x.
Full textPham, Duc-Truc, Huy Tien Ngo, Stephen F. Lincoln, Bruce L. May та Christopher J. Easton. "Synthesis of C6A-to-C6A and C3A-to-C3A diamide linked γ-cyclodextrin dimers". Tetrahedron 66, № 15 (2010): 2895–98. http://dx.doi.org/10.1016/j.tet.2010.02.005.
Full textTAKEMATSU, H., K. OHKOHCHI, and H. TAGAMI. "Demonstration of anaphylatoxins C3a, C4a and C5a in the scales of psoriasis and inflammatory pustular dermatoses." British Journal of Dermatology 114, no. 1 (1986): 1–6. http://dx.doi.org/10.1111/j.1365-2133.1986.tb02773.x.
Full textKasuya, Hidetoshi, and Takashi Shimizu. "Activated complement components C3a and C4a in cerebrospinal fluid and plasma following subarachnoid hemorrhage." Journal of Neurosurgery 71, no. 5 (1989): 741–46. http://dx.doi.org/10.3171/jns.1989.71.5.0741.
Full textRua-Figueroa, I., O. Arencibia-Mireles, M. Elvira, et al. "Factors involved in the progress of preclinical atherosclerosis associated with systemic lupus erythematosus: a 2-year longitudinal study." Annals of the Rheumatic Diseases 69, no. 6 (2009): 1136–39. http://dx.doi.org/10.1136/ard.2008.104349.
Full textStrey, C. W., B. Siegmund, R. Marquez-Pinilla, E. Oppermann, and W. O. Bechstein. "C3a, C4a and C5a plasma levels change after liver resection in correlation with a systemic chemokine response." Molecular Immunology 44, no. 1-3 (2007): 245. http://dx.doi.org/10.1016/j.molimm.2006.07.232.
Full textKATO, Y. "Purification and functional assessment of C3a, C4a and C5a of the common carp (Cyprinus carpio) complement*1." Developmental & Comparative Immunology 28, no. 9 (2004): 901–10. http://dx.doi.org/10.1016/j.dci.2004.01.006.
Full textDeb-Chatterji, Milani, Christian W. Keller, Simon Koch, et al. "Profiling Complement System Components in Primary CNS Vasculitis." Cells 10, no. 5 (2021): 1139. http://dx.doi.org/10.3390/cells10051139.
Full textPham, Duc-Truc, Huy Tien Ngo, Stephen F. Lincoln, Bruce L. May та Christopher J. Easton. "ChemInform Abstract: Synthesis of C6A-to-C6A and C3A-to-C3A Diamide Linked γ-Cyclodextrin Dimers." ChemInform 41, № 29 (2010): no. http://dx.doi.org/10.1002/chin.201029205.
Full textBajic, Goran, Laure Yatime, Andreas Klos, and Gregers Rom Andersen. "Human C3a and C3a desArg anaphylatoxins have conserved structures, in contrast to C5a and C5a desArg." Protein Science 22, no. 2 (2012): 204–12. http://dx.doi.org/10.1002/pro.2200.
Full textYoun, So Won. "Transition-Metal-Catalyzed Annulative Coupling Cascade for the Synthesis of 3-Methyleneisoindolin-1-ones." Synthesis 52, no. 06 (2020): 807–18. http://dx.doi.org/10.1055/s-0039-1690046.
Full textPfeifer, Philippe H., Marleen S. Kawahara, and Tony E. Hugli. "Possible Mechanism for in Vitro Complement Activation in Blood and Plasma Samples: Futhan/EDTA Controls in Vitro Complement Activation." Clinical Chemistry 45, no. 8 (1999): 1190–99. http://dx.doi.org/10.1093/clinchem/45.8.1190.
Full textPrendecki, Maria, Candice Clarke, Nicholas Medjeral-Thomas, et al. "Temporal changes in complement activation in haemodialysis patients with COVID-19 as a predictor of disease progression." Clinical Kidney Journal 13, no. 5 (2020): 889–96. http://dx.doi.org/10.1093/ckj/sfaa192.
Full textSchraufstaetter, Ingrid U., Richard DiScipio, and Sophia K. Khaldoyanidi. "Complement C3a Enhances the Repair Potential of Human Mesenchymal Stem Cells." Blood 118, no. 21 (2011): 1324. http://dx.doi.org/10.1182/blood.v118.21.1324.1324.
Full textStrey, Christoph W., Maciej Markiewski, Dimitrios Mastellos, et al. "The Proinflammatory Mediators C3a and C5a Are Essential for Liver Regeneration." Journal of Experimental Medicine 198, no. 6 (2003): 913–23. http://dx.doi.org/10.1084/jem.20030374.
Full textFoley, J. H., and E. M. Conway. "Basic weapons to degrade C3a and C5a." Journal of Thrombosis and Haemostasis 16, no. 5 (2018): 987–90. http://dx.doi.org/10.1111/jth.13999.
Full textGutzmer, Ralf, Brigitta Köther, Jörg Zwirner, et al. "Human Plasmacytoid Dendritic Cells Express Receptors for Anaphylatoxins C3a and C5a and Are Chemoattracted to C3a and C5a." Journal of Investigative Dermatology 126, no. 11 (2006): 2422–29. http://dx.doi.org/10.1038/sj.jid.5700416.
Full textNAGATA, S., and M. GLOVSKY. "Activation of human serum complement with allergensI. Generation of C3a, C4a, and C5a and induction of human neutrophil aggregation." Journal of Allergy and Clinical Immunology 80, no. 1 (1987): 24–32. http://dx.doi.org/10.1016/s0091-6749(87)80186-0.
Full textPerret, J. J., E. Raspe, G. Vassart, and M. Parmentier. "Cloning and functional expression of the canine anaphylatoxin C5a receptor. Evidence for high interspecies variability." Biochemical Journal 288, no. 3 (1992): 911–17. http://dx.doi.org/10.1042/bj2880911.
Full textJalili, Ali, Neeta Shirvaikar, Chris Korol, and Anna Janowska-Wieczorek. "The Role of C5a in the Mobilization of Hematopoietic Stem/Progenitor Cells." Blood 112, no. 11 (2008): 3472. http://dx.doi.org/10.1182/blood.v112.11.3472.3472.
Full textFreyria, A. M., Ph Leitienne, C. N. Veysseyre, J. P. Bringuier, and J. Traeger. "Complement C3 and C5 Degradation Products during Hemodialysis Treatment: Study of an Index of Membrane Bioincompatibility." International Journal of Artificial Organs 11, no. 2 (1988): 111–18. http://dx.doi.org/10.1177/039139888801100211.
Full textWestcott, Stephen A., Nicholas J. Taylor та Todd B. Marder. "Reactions of (η5-C9H7)Rh(η2-C2H4)2 with quinones: molecular structure of [(η5-C9H7)Rh(2,3,5,6-C6O2(CH3)4)]". Canadian Journal of Chemistry 77, № 2 (1999): 199–204. http://dx.doi.org/10.1139/v98-228.
Full textFareed, Jawed, Debra A. Hoppensteadt, Fred Leya, Omer Iqbal, Helmut Wolf, and Roger Bick. "Useful laboratory tests for studying thrombogenesis in acute cardiac syndromes." Clinical Chemistry 44, no. 8 (1998): 1845–53. http://dx.doi.org/10.1093/clinchem/44.8.1845.
Full textJayakody Arachchillage, Deepa, Ian J. Mackie, Maria Efthymiou, et al. "Rivaroxaban Limits Complement Activation Compared to Warfarin in Antiphospholipid Syndrome Patients with Venous Thromboembolism." Blood 126, no. 23 (2015): 2328. http://dx.doi.org/10.1182/blood.v126.23.2328.2328.
Full textSchleuning, M., M. Schmid-Haslbeck, H. Utz, et al. "Complement activation during storage of blood under normal blood bank conditions. Effects of proteinase inhibitors and leukocyte depletion." Blood 79, no. 11 (1992): 3071–75. http://dx.doi.org/10.1182/blood.v79.11.3071.3071.
Full textSchleuning, M., M. Schmid-Haslbeck, H. Utz, et al. "Complement activation during storage of blood under normal blood bank conditions. Effects of proteinase inhibitors and leukocyte depletion." Blood 79, no. 11 (1992): 3071–75. http://dx.doi.org/10.1182/blood.v79.11.3071.bloodjournal79113071.
Full textHartmann, Karin, Beate M. Henz, Sabine Krüger-Krasagakes, et al. "C3a and C5a Stimulate Chemotaxis of Human Mast Cells." Blood 89, no. 8 (1997): 2863–70. http://dx.doi.org/10.1182/blood.v89.8.2863.
Full textChiummiento, Lucia, Rosarita D’Orsi, Maria Funicello, and Paolo Lupattelli. "Last Decade of Unconventional Methodologies for the Synthesis of Substituted Benzofurans." Molecules 25, no. 10 (2020): 2327. http://dx.doi.org/10.3390/molecules25102327.
Full textIssekutz, Andrew C., Dennis M. Roland, and Richard A. Patrick. "The effect of FUT-175 (nafamstat mesilate) on C3a, C4a and C5a generation in vitro and inflammatory reactions in vivo." International Journal of Immunopharmacology 12, no. 1 (1990): 1–9. http://dx.doi.org/10.1016/0192-0561(90)90062-r.
Full textFrancis, Karen, B. Mary Lewis, Peter N. Monk, and Jack Ham. "Complement C5a receptors in the pituitary gland: expression and function." Journal of Endocrinology 199, no. 3 (2008): 417–24. http://dx.doi.org/10.1677/joe-08-0110.
Full textPeng, Qi, Ke Li, Lesley A. Smyth, et al. "C3a and C5a Promote Renal Ischemia-Reperfusion Injury." Journal of the American Society of Nephrology 23, no. 9 (2012): 1474–85. http://dx.doi.org/10.1681/asn.2011111072.
Full textOHKOHCHI, K., H. TAKEMATSU, and H. TAGAMI. "Increased anaphylatoxins (C3a and C4a) in psoriatic sera." British Journal of Dermatology 113, no. 2 (1985): 189–96. http://dx.doi.org/10.1111/j.1365-2133.1985.tb02064.x.
Full textMastroroberto, Pasquale, Massimo Chello, and Antonietta R. Marchese. "Plasma C3a and C5a concentrations during cardiopulmonary bypass." Annals of Thoracic Surgery 57, no. 3 (1994): 781–82. http://dx.doi.org/10.1016/0003-4975(94)90599-1.
Full text